Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements by Fangfang Gao, Fangfang Gao, Huijuan Wu, Junfeng Lu, Yaping Xu, Yanqiu Zhao

Subjects: “…ALK rearrangement…”
Get full text

Comparison of salvage surgeries for lung adenocarcinoma treated with anaplastic lymphoma kinase-tyrosine kinase inhibitors by Naoya Iwamoto, Yosuke Matsuura, Hironori Ninomiya, Ken Uchibori, Noriko Yanagitani, Kohei Hashimoto, Junji Ichinose, Masayuki Nakao, Sakae Okumura, Makoto Nishio, Mingyon Mun

Subjects: “…ALK-rearrangement…”
Get full text

Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection by Sonoda D, Matsuura Y, Ichinose J, Nakao M, Ninomiya H, Mun M, Ishikawa Y, Nakagawa K, Satoh Y, Okumura S

Subjects: Get full text

ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma by Rui Bi, Qianming Bai, Xiaoli Zhu, Xiaoyu Tu, Xu Cai, Wenhua Jiang, Xiaoli Xu, Shaoxian Tang, Huijuan Ge, Bin Chang, Yufan Cheng, Hualei Gan, Xiaoyan Zhou, Wentao Yang

Subjects: Get full text

Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer—is there a “tail plateau” in the survival curve of these patients? by Shoko Sonobe Shimamura, Takehito Shukuya, Tetsuhiko Asao, Daisuke Hayakawa, Kana Kurokawa, Shiting Xu, Keita Miura, Yoichiro Mitsuishi, Ken Tajima, Rina Shibayama, Naoko Shimada, Fumiyuki Takahashi, Kazuhisa Takahashi

Subjects: Get full text

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives by Giroux Leprieur E, Fallet V, Cadranel J, Wislez M

Subjects: “…ALK rearrangement…”
Get full text

Fatal Haemoptysis Associated with Dramatic Response to Crizotinib in an ALK-Rearranged Lung Adenocarcinoma by Elodie Mussat, Violaine Giraud, Catherine Julie, Thierry Chinet, Etienne Giroux Leprieur

Subjects: “…alk rearrangement…”
Get full text

Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors by Schrock AB, Madison R, Rosenzweig M, Allen JM, Erlich RL, Wang SY, Chidiac T, Reddy VS, Riess JW, Yassa AE, Shakir A, Miller VA, Alexander BM, Venstrom J, McGregor K, Ali SM

Subjects: “…alk rearrangement…”
Get full text

Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement by Seto K, Kuroda H, Yoshida T, Sakata S, Mizuno T, Sakakura N, Hida T, Yatabe Y, Sakao Y

Subjects: Get full text

Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report by Ji Eun Park, Young‐Ran Yoon, Chang Ho Kim, Jaehee Lee

Subjects: Get full text

ALK rearrangements as mechanisms of acquired resistance to osimertinib in EGFR mutant non‐small cell lung cancer by Helei Hou, Dantong Sun, Chuantao Zhang, Dong Liu, Xiaochun Zhang

Subjects: Get full text

Durable Complete Response to Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases and Low-Abundance EML4-ALK Variant in Liquid Biopsy: A Case Report by Yingying Zhu, Ran Jia, Yang W. Shao, Liuqing Zhu, Qiuxiang Ou, Man Yu, Xue Wu, Yanbei Zhang

Subjects: Get full text

Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations by Xiaodan Yang, Jia Zhong, Zhuo Yu, Minglei Zhuo, Min Zhang, Rongrong Chen, Xuefeng Xia, Jun Zhao

Subjects: Get full text

Complete response to alectinib following crizotinib in an ALK-positive inflammatory myofibroblastic tumor with CNS involvement by Camila B. Xavier, Felipe S.N.A. Canedo, Fabíola A.S. Lima, Raíssa R. Melo, Luiz Guilherme C.A. Lima, José Flávio G. Marin, Ciro E. Souza, Olavo Feher

Subjects: Get full text

A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib by Yuki Matsumura, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Masayuki Watanabe, Yuki Ozaki, Takumi Yamaura, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Takeo Hasegawa, Yutaka Shio, Hiroyuki Suzuki

Subjects: Get full text

Case Report: Response to ALK-TKIs in a metastatic lung cancer patient with morphological heterogeneity and consistent molecular features by Yu Yang, Han Liu, Tao-hua Liu, Xi-run Zheng, Bin Wu, Dong-jing Zhou, Guang-juan Zheng, Xiao-shu Chai

Subjects: Get full text

Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer by Rui Kitadai, Yusuke Okuma, Jumpei Kashima

Subjects: Get full text

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report by Dan Li, Yue Zhu, Jincheng Song, Dafu Yang, Saiqiong Cui, Xin Liu, Le Wang, Jiangyan Zhang, Evenki Pan, Zhaoxia Dai

Subjects: “…ALK rearrangement…”
Get full text

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer by Haoyue Hu, Songtao Tan, Songtao Tan, Meng Xie, Peng Guo, Qiang Yu, Qiang Yu, Juan Xiao, Kangrui Zhao, Qiong Liao, Yi Wang

Subjects: “…ALK rearrangement…”
Get full text

Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports by Liang Shi, Shuhong Gao, Li Tong, Qiyi Meng, Shijie Zhou, Daping Yu, Yujie Dong, Zhe Liu

Subjects: Get full text